Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
133 studies found for:    HEPATITIS B VACCINE, RESPONSE TO
Show Display Options
Rank Status Study
1 Completed Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator
Condition: Hepatitis B
Intervention: Biological: Resiquimod gel
2 Completed
Has Results
The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
3 Recruiting A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines
Condition: Hepatitis B
Interventions: Biological: Engerix B IM injection - 20ug;   Biological: Fendrix IM injection - 20ug
4 Completed Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
Conditions: Hepatitis B;   Immune Response;   Seroprevalence
Intervention: Biological: HBV vaccine (Engerix-B, recombinant hepatitis B surface antigen, 20µg/mL/vial, GlaxoSmithKline, Belgium)
5 Completed
Has Results
Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children
Condition: Hepatitis B
Intervention: Biological: Engerix-B™ Kinder
6 Active, not recruiting Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
Conditions: Chronic Hepatitis B;   Inadequate Response;   Nucleos(t)Ide Analogues Treatment
Intervention: Drug: Entecavir, Adefovir
7 Completed Dose of Hepatitis B Vaccines in Non/Low-response Populations
Condition: Vaccination; Complications, Reaction, Serum
Intervention: Biological: hepatitis B vaccine
8 Completed
Has Results
Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.
Condition: Hepatitis B
Intervention: Biological: Engerix™-B
9 Recruiting The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults
Condition: Hepatitis B
Interventions: Drug: Alendronate;   Drug: Hepatitis B Vaccine;   Drug: Placebo
10 Unknown  Adolescents' Response to Hepatitis B Vaccine Booster Dose
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
11 Completed Observational Study of Immune Response to Hepatitis B Childhood Booster
Condition: Healthy
Intervention: Biological: Engerix B®, a recombinant hepatitis B vaccine
12 Completed Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge
Condition: Hepatitis B
Intervention: Biological: Engerix™-B Kinder
13 Active, not recruiting Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
Condition: Hepatitis B
Interventions: Drug: Entecavir;   Drug: Entecavir, Adefovir
14 Completed Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth
Conditions: Hib Disease;   Hepatitis B;   Diphtheria;   Pertussis;   Neisseria Meningitidis Serogroup Diseases;   Tetanus
Intervention: Biological: DTPw-HBV/Hib-MenAC conjugate vaccine
15 Active, not recruiting Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Alfa-2b Treatment to Increase Sustained Response in HBeAg-positive Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: peginterferon alpha-2b
16 Completed Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants
Conditions: Hib Disease;   Hepatitis B;   Diphtheria;   Pertussis;   Neisseria Meningitidis Serogroup Diseases;   Tetanus
Intervention: Biological: DTPw-HBV/Hib-MenAC conjugate vaccine
17 Recruiting Immune Response to HBV Booster Vaccination After 20-23 Years
Condition: Hepatitis B Vaccination
Intervention: Biological: HBV booster vaccination 1dose
18 Recruiting HBsAg Related Response Guided Therapy
Condition: Hepatitis B, Chronic
Interventions: Drug: Peginterferon alfa-2a;   Drug: Entecavir
19 Active, not recruiting A Study of the Immune Response to Heplisav in Healthy Older Adults
Condition: Hepatitis B
Intervention: Biological: HEPLISAV
20 Completed PEG-IFN in HBV Patients With Incomplete Response to NA
Condition: Chronic Hepatitis B
Interventions: Drug: Nucleos(t)ide analogue treatment with a peginterferon add-on strategy;   Drug: Nucleos(t)ide analogue treatment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years